FUNCTIONAL CONNECTIVITY FROM CA3 TO THE IPSILATERAL AND CONTRALATERAL CA1 IN THE RAT DORSAL HIPPOCAMPUS

被引:36
|
作者
FINNERTY, GT [1 ]
JEFFERYS, JGR [1 ]
机构
[1] IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT PHYSIOL & BIOPHYS,NORFOLK PL,LONDON W2 1PG,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1016/0306-4522(93)90566-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Anatomical advances have led to a reappraisal of the organization of hippocampal circuitry. However, it is not clear whether the functional connectivity is fully determined by the anatomical connectivity or whether it is significantly modified by feed-forward inhibition and modulatory inputs. Therefore, we have mapped CA1 responses evoked by stimulation of ipsilateral and contralateral CA3 in vivo. Population spike amplitude and threshold were plotted to produce response maps. All CA3 subregions projected diffusely to ipsilateral CA1. However, a pattern of maximal response emerged. Caudal CA3 stimulation evoked the maximal responses septally, while rostral CA3 responses were maximal temporally. The ipsilateral CA3 response maps were compared with those produced by stimulation at the homotopic point in the contralateral CA3. The CA1 areas of maximal functional connectivity were the same implying that there is convergence of the input to CA1 from homotopic CA3 sites in the two hippocampi. Although a response in CA1 was evoked widely, our results suggest that the functional connectivity is ordered, within and between the dorsal hippocampi, and that it is consistent with the recent anatomical data. The present findings allow more precise study of the propagation of normal and abnormal neuronal activity, within and between the dorsal hippocampi. Information on the site and speed of propagation of neuronal activity would be necessary for the development of a physiologically realistic model of hippocampal computation.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 50 条
  • [41] Functional MRI of rat's CCH in hippocampus CA1 domain
    Zhang, L.
    Zhou, H.
    Li, Y.
    Xiang, Y.
    Shu, X.
    Liu, L.
    CEREBROVASCULAR DISEASES, 2007, 24 (06) : 487 - 488
  • [42] Lateralization of CA1 assemblies in the absence of CA3 input
    Hefei Guan
    Steven J. Middleton
    Takafumi Inoue
    Thomas J. McHugh
    Nature Communications, 12
  • [43] Ensemble dynamics of hippocampal regions CA3 and CA1
    Guzowski, JF
    Knierim, JJ
    Moser, EI
    NEURON, 2004, 44 (04) : 581 - 584
  • [44] Lateralization of CA1 assemblies in the absence of CA3 input
    Guan, Hefei
    Middleton, Steven J.
    Inoue, Takafumi
    McHugh, Thomas J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [45] Functional heterogeneity of astrocytes in the CA1 hippocampus
    Clarke, D.
    Bosson, A.
    Avignone, E.
    Lacaille, J. C.
    Robitaille, R.
    GLIA, 2023, 71 : E523 - E523
  • [46] ENDOGENOUS ADENOSINE MODULATES [H-3] ACETYLCHOLINE-RELEASE IN THE CA1 AND CA3 AREAS OF THE RAT HIPPOCAMPUS BUT NOT IN THE DENTATE GYRUS
    CUNHA, RA
    MILUSHEVA, E
    SEBASTIAO, AM
    VIZI, ES
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S80 - S80
  • [47] GABAergic and asymmetrical synapses on somata of GABAergic neurons in CA1 and CA3 regions of rat hippocampus - A quantitative electron microscopic analysis
    Yao, ZB
    Li, XD
    Xu, ZC
    STROKE, 1996, 27 (08) : 1411 - 1415
  • [48] Nitric oxide affects LTP in area CA1 and CA3 of hippocampus in low-level lead-exposed rat
    Xu, YZ
    Ruan, DY
    Wu, Y
    Jiang, YB
    Chen, SY
    Chen, JT
    Shi, P
    NEUROTOXICOLOGY AND TERATOLOGY, 1998, 20 (01) : 69 - 73
  • [49] INTRAUTERINE GROWTH RESTRICTION INCREASES ESTROGEN RECEPTOR ALPHA PROTEIN LEVELS IN THE CA1 AND CA3 REGIONS OF THE MALE RAT HIPPOCAMPUS
    Numpang, B.
    Ke, X.
    Yu, X.
    Callaway, C.
    McKnight, R.
    Joss-Moore, L.
    Lane, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 239 - 239
  • [50] The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus
    Vignes, M
    Clarke, VRJ
    Parry, MJ
    Bleakman, D
    Lodge, D
    Ornstein, PL
    Collingridge, GL
    NEUROPHARMACOLOGY, 1998, 37 (10-11) : 1269 - 1277